Everest Medicines' (HKG:1952) honorary chairman and substantial shareholder, Wei Fu, increased his stake in the company via the purchase of shares, according to a Thursday filing with the Hong Kong bourse.
The 690,000 shares were acquired from the open market on June 3 for about HK$20 million at an average price of about HK$28.93 apiece.